European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 147, Issue 2 , Pages 124-129 , December 2009

Accuracy of C-reactive protein determination in predicting chorioamnionitis and neonatal infection in pregnant women with premature rupture of membranes: A systematic review

  • Rafli van de Laar

      Affiliations

    • Department of Obstetrics & Gynaecology, Maastricht University Medical Centre, GROW – School for Oncology and Developmental Biology, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    • ,
  • David P. van der Ham

      Affiliations

    • Department of Obstetrics & Gynaecology, Maastricht University Medical Centre, GROW – School for Oncology and Developmental Biology, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 0 43 3874768; fax: +31 0 43 3874765.
    • ,
  • S. Guid Oei

      Affiliations

    • Department of Obstetrics and Gynaecology, Máxima Medical Centre, De Run 4600 PO Box 7777, 5500 MB Veldhoven, The Netherlands
    • ,
  • Christine Willekes

      Affiliations

    • Department of Obstetrics & Gynaecology, Maastricht University Medical Centre, GROW – School for Oncology and Developmental Biology, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    • ,
  • Carl P. Weiner

      Affiliations

    • Department of Obstetrics and Gynecology, University of Kansas School of Medicine, 3901 Rainbow Boulevard, MS 2028 Kansas City, KS 66160-7316, USA
    • ,
  • Ben W.J. Mol

      Affiliations

    • Department of Obstetrics and Gynaecology, Máxima Medical Centre, De Run 4600 PO Box 7777, 5500 MB Veldhoven, The Netherlands
    • Department of Obstetrics & Gynaecology, Academic Medical Centre, PO Box 22700, 1105 DE Amsterdam, The Netherlands

Received 21 January 2009 ,Revised 30 June 2009 ,Accepted 15 September 2009.

References 

  1. Mercer BM, Goldenberg RL, Meis PJ, Moawad AH, Shellhaas C, Das A, et al. The Preterm Prediction Study: prediction of preterm premature rupture of membranes through clinical findings and ancillary testing, The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 2000;183(September (3)):738–745
  2. Merenstein GB, Weisman LE. Premature rupture of the membranes: neonatal consequences. Semin Perinatol. 1996;20(October (5)):375–380
  3. Furman B, Shoham-Vardi I, Bashiri A, Erez O, Mazor M. Clinical significance and outcome of preterm prelabor rupture of membranes: population-based study. Eur J Obstet Gynecol Reprod Biol. 2000;92(October (2)):209–216
  4. Ibarra Chavarria V, Sanhueza Smith P, Mota Gonzalez M, del Rey Pineda G, Karchmer S. C-reactive protein as early marker of chorioamnionitis in premature rupture of membranes. Ginecol Obstet Mex. 1989;57(August):203–208
  5. Hawrylyshyn P, Bernstein P, Milligan JE, Soldin S, Pollard A, Papsin FR. Premature rupture of membranes: the role of C-reactive protein in the prediction of chorioamnionitis. Am J Obstet Gynecol. 1983;147(October (3)):240–246
  6. Dodds WG, Iams JD. Maternal C-reactive protein and preterm labor. J Reprod Med. 1987;32(July (7)):527–530
  7. Romem Y, Artal R. C-reactive protein as a predictor for chorioamnionitis in cases of premature rupture of the membranes. Am J Obstet Gynecol. 1984;150(November (5 Pt 1)):546–550
  8. Evans MI, Hajj SN, Devoe LD, Angerman NS, Moawad AH. C-reactive protein as a predictor of infectious morbidity with premature rupture of membranes. Am J Obstet Gynecol. 1980;138(November (6)):648–652
  9. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3(November):25
  10. Trochez-Martinez RD, Smith P, Lamont RF. Use of C-reactive protein as a predictor of chorioamnionitis in preterm prelabor rupture of membranes: a systematic review. BJOG. 2007;114(July (7)):796–801
  11. Sereepapong W, Limpongsanurak S, Triratanachat S, Wannakrairot P, Charuruks N, Krailadsiri P. The role of maternal serum C-reactive protein and white blood cell count in the prediction of chorioamnionitis in women with premature rupture of membranes. J Med Assoc Thai. 2001;84(June (Suppl 1)):S360–S366
  12. Kurki T, Teramo K, Ylikorkala O, Paavonen J. C-reactive protein in preterm premature rupture of the membranes. Arch Gynecol Obstet. 1990;247(1):31–37
  13. Yoon BH, Jun JK, Park KH, Syn HC, Gomez R, Romero R. Serum C-reactive protein, white blood cell count, and amniotic fluid white blood cell count in women with preterm premature rupture of membranes. Obstet Gynecol. 1996;88(December (6)):1034–1040
  14. Bankowska EM, Leibschang J, Pawlowska A. Usefulness of determination of granulocyte elastase plasma level, C-reactive protein and white blood cell count in prediction in intrauterine infection in pregnant women after PROM. Ginekol Pol. 2003;74(October (10)):1037–1043
  15. Nowak M, Oszukowski P, Szpakowski M, Malinowski A, Maciolek-Blewniewska G. Intrauterine infections. I. The role of C-reactive protein, white blood cell count and erythrocyte sedimentation rate in pregnant women in the detection of intrauterine infection after preliminary rupture of membranes. Ginekol Pol. 1998;69(August (8)):615–622
  16. Lieman JM, Brumfield CG, Carlo W, Ramsey PS. Preterm premature rupture of membranes: is there an optimal gestational age for delivery?. Obstet Gynecol. 2005;105(January (1)):12–17
  17. Deeks JJ. Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ. 2001;323(July (7305)):157–162
  18. Van Houwelingen HC, Zwinderman KH, Stijnen T. A bivariate approach to meta-analysis. Stat Med. 1993;12(December (24)):2273–2284
  19. van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med. 2002;21(February (4)):589–624
  20. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005;58(October (10)):982–990
  21. He JP. C-reactive protein and acute-phase proteins in monitoring infection caused by premature rupture of membranes. Zhonghua Fu Chan Ke Za Zhi. 1990;25(March (2)):98–101
  22. Tiufekchieva E. C-reactive protein as an index of amniotic infection in premature rupture of the amniotic sac. Akush Ginekol (Sofiia). 1985;24(6):35–41
  23. Gonik B, Weiner C, James D, Steer P. In: High risk pregnancy management options. 3rd ed.. Philadelphia: W.B. Saunders Company; 2005;
  24. Ismail MA, Zinaman MJ, Lowensohn RI, Moawad AH. The significance of C-reactive protein levels in women with premature rupture of membranes. Am J Obstet Gynecol. 1985;151(February (4)):541–544
  25. Berardi JC, Hutin S, Godard J, Madinier V, Delanete A, Berardi-Grassias L. The value of C-reactive protein in the detection of chorioamnionitis in cases of premature rupture of membranes. Rev Fr Gynecol Obstet. 1991;86(March (3)):229–232
  26. Fisk NM, Fysh J, Child AG, Gatenby PA, Jeffery H, Bradfield AH. Is C-reactive protein really useful in preterm premature rupture of the membranes?. Br J Obstet Gynaecol. 1987;94(December (12)):1159–1164
  27. Farb HF, Arnesen M, Geistler P, Knox GE. C-reactive protein with premature rupture of membranes and premature labor. Obstet Gynecol. 1983;62(July (1)):49–51
  28. Ramsey PS, Lieman JM, Brumfield CG, Carlo W. Chorioamnionitis increases neonatal morbidity in pregnancies complicated by preterm premature rupture of membranes. Am J Obstet Gynecol. 2005;192(April (4)):1162–1166
  29. Williams H, Jeffery H. The incidence of histological chorioamnionitis in IVF/GIFT preterm births. Aust N Z J Obstet Gynaecol. 1994;34(August (4)):480–483
  30. Benirschke K. Examination of the placenta. Obstet Gynecol. 1961;66:316–321
  31. Russell P. Inflammatory lesions of the human placenta. I. Clinical significance of acute chorioamnionitis. Am J Diagn Gynecol Obstet. 1979;1:127–137
  32. Naeye RL, Peters EC. Causes and consequences of premature rupture of fetal membranes. Lancet. 1980;1(January (8161)):192–194

PII: S0301-2115(09)00555-7

doi: 10.1016/j.ejogrb.2009.09.017

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 147, Issue 2 , Pages 124-129 , December 2009

Article Tools

* Image Usage & Resolution